BOOSTRIX Settlement Ends Class Action Lawsuit Over Allegedly Misleading Advertisements
March 20, 2026 A BOOSTRIX class action settlement offers cash to certain consumers who received the BOOSTRIX whooping cough vaccine.
Lawsuit Filings
Certain OTC Cold Symptom Medications Fail to Provide Decongestant Relief as Advertised, Pharmacy Alleges
October 3, 2023 A retail pharmacy claims in a class action that several consumer health companies have misled the public by marketing over-the-counter medications containing phenylephrine as effective nasal decongestants.
Active Ingredient in Hundreds of Cold and Flu Meds Is ‘Entirely Ineffective,’ Class Action Says
September 13, 2023 A class action alleges fourteen companies make and/or sell over-the-counter cold and flu medicines with an active ingredient that is ineffective at treating nasal congestion.